Author:
Capdeville Renaud,Silberman Sandra
Reference36 articles.
1. Response to imatinib mesylate in patients with myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta;Apperley;N Engl J Med,2002
2. The Abl protein-tyrosine kinase inhibitor, STI571, inhibits in vitro signal transduction mediated by c-Kit and PDGF receptors;Buchdunger;J Pharmacol Exp Ther,2000
3. Imatinib (STI571, imatinib), a rationally developed targeted anticancer drug;Capdeville;Nat Rev Drug Discovery,2002
4. STI571 in the treatment of children with Philadelphia chromosome positive leukemia: Results from a Children's Oncology Group (COG) phase I study;Champagne;Blood,2001
5. Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献